Cerebral net exchange of large neutral amino acids after lipopolysaccharide infusion in healthy humans

Critical Care

Volumn 14, Issue 1, 2010, Pages

  Berg, Ronan M G ^a   Taudorf, Sarah ^a   Bailey, Damian M ^b   Lundby, Carsten ^a   Larsen, Fin S ^a   Pedersen, Bente K ^a   Møller, Kirsten ^a  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b UNIVERSITY OF GLAMORGAN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GLUTAMINE; ISOLEUCINE; LEUCINE; PHENYLALANINE; AMINO ACID; BIOLOGICAL MARKER; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRAIN FUNCTION; HUMAN; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; ADULT; BLOOD; BRAIN; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; REFERENCE VALUE;

ADULT; AMINO ACIDS; AMMONIA; BIOLOGICAL MARKERS; BRAIN; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; REFERENCE VALUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77949469569     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8873     Document Type: Article

References (44)

1. Bolton CF, Young GB, Zochodne DW. The neurological complications of sepsis. Ann Neurol 1993, 33:94-100. 10.1002/ana.410330115, 8388191.
2. Sprung CL, Peduzzi PN, Shatney CH, Schein RM, Wilson MF, Sheagren JN, Hinshaw LB. Impact of encephalopathy on mortality in the sepsis syndrome: the Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med 1990, 18:801-806.
3. Young GB, Bolton CF, Austin TW, Archibald YM, Gonder J, Wells GA. The encephalopathy associated with septic illness. Clin Invest Med 1990, 13:297-304.
4. Papadopoulos MC, Davies DC, Moss RF, Tighe D, Bennett ED. Pathophysiology of septic encephalopathy: a review. Crit Care Med 2000, 28:3019-3024. 10.1097/00003246-200008000-00057, 10966289.
5. Gamrin L, Andersson K, Hultman E, Nilsson E, Essen P, Wernerman J. Longitudinal changes of biochemical parameters in muscle during critical illness. Metabolism 1997, 46:756-762. 10.1016/S0026-0495(97)90119-0, 9225828.
6. Vesali RF, Klaude M, Rooyackers OE, Tjäder I, Barle H, Wernerman J. Longitudinal pattern of glutamine/glutamate balance across the leg in long-stay intensive care unit patients. Clin Nutr 2002, 21:505-514. 10.1054/clnu.2002.0583, 12468371.
7. Vente JP, von Meyenfeldt MF, van Eijk HM, van Berlo CL, Gouma DJ, Linden CJ, Soeters PB. Plasma-amino acid profiles in sepsis and stress. Ann Surg 1989, 209:57-62. 10.1097/00000658-198901000-00009, 1493873, 2910215.
8. Freund HR, Muggia-Sullam M, LaFrance R, Holroyde J, Fischer JE. Regional brain amino acid and neurotransmitter derangements during abdominal sepsis and septic encephalopathy in the rat: the effect of amino acid infusions. Arch Surg 1986, 121:209-216.
9. Basler T, Meier-Hellmann A, Bredle D, Reinhart K. Amino acid imbalance early in septic encephalopathy. Intensive Care Med 2002, 28:293-298. 11904658, 10.1007/s00134-002-1217-6.
10. Smith QR, Momma S, Aoyagi M, Rapoport SI. Kinetics of neutral amino acid transport across the blood-brain barrier. J Neurochem 1987, 49:1651-1658. 10.1111/j.1471-4159.1987.tb01039.x, 3668544.
11. Freund H, Atamian S, Holroyde J, Fischer JE. Plasma amino acids as predictors of the severity and outcome of sepsis. Ann Surg 1979, 190:571-576. 1344534, 389183.
12. Taudorf S, Krabbe KS, Berg RMG, Pedersen BK, Møller K. Human models of low-grade inflammation: bolus versus continuous infusion of endotoxin. Clin Vaccine Immunol 2007, 14:250-255. 10.1128/CVI.00380-06, 1828854, 17267590.
13. Taudorf S, Berg RMG, Bailey DM, Møller K. Cerebral blood flow and oxygen metabolism measured with the Kety-Schmidt method using nitrous oxide. Acta Anaesthesiol Scand 2009, 53:159-167. 10.1111/j.1399-6576.2008.01788.x, 19076112.
14. Felig P, Wahren J, Raf L. Evidence of inter-organ amino-acid transport by blood cells in humans. Proc Natl Acad Sci USA 1973, 70:1775-1779. 10.1073/pnas.70.6.1775, 433594, 4515937.
15. Hagenfeldt L, Arvidsson A. The distribution of amino acids between plasma and erythrocytes. Clin Chim Acta 1980, 100:133-141. 10.1016/0009-8981(80)90074-1, 7351084.
16. Drewes LR, Conway WP, Gilboe DD. Net amino acid transport between plasma and erythrocytes and perfused dog brain. Am J Physiol 1977, 233:E320-E325.
17. Strauss GI, Knudsen GM, Kondrup J, Møller K, Larsen FS. Cerebral metabolism of ammonia and amino acids in patients with fulminant hepatic failure. Gastroenterology 2001, 121:1109-1119. 10.1053/gast.2001.29310, 11677203.
18. Møller SE. Quantification of physiological amino acids by gradient ion-exchange high-performance liquid chromatography. J Chromatogr 1993, 613:223-230. 10.1016/0378-4347(93)80136-R, 8491808.
19. Bosoi CR, Rose CF. Identifying the direct effects of ammonia on the brain. Metab Brain Dis 2009, 24:95-102. 10.1007/s11011-008-9112-7, 19104924.
20. Conn HO. Studies on the origin and significance of blood ammonia, II: the distribution of ammonia in whole blood, plasma and erythrocytes of man. Yale J Biol Med 1966, 39:38-53. 2591254, 5975536.
21. Fischer JE, Funovics JM, Aguirre A, James JH, Keane JM, Wesdorp RI, Yoshimura N, Westman T. The role of plasma amino acids in hepatic encephalopathy. Surgery 1975, 78:276-290.
22. Fick A. Über die Messung des Blutquantums in den Herzventrikeln. Verh Phys Med Ges Würzburg 1870, 2:16.
23. Knudsen GM, Pettigrew KD, Patlak CS, Hertz MM, Paulson OB. Asymmetrical transport of amino acids across the blood-brain barrier in humans. J Cereb Blood Flow Metab 1990, 10:698-706.
24. Knudsen GM, Hasselbalch S, Toft PB, Christensen E, Paulson OB, Lou H. Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria. J Inherit Metab Dis 1995, 18:653-664. 10.1007/BF02436753, 8750601.
25. Choi TB, Pardridge WM. Phenylalanine transport at the human blood-brain barrier: studies with isolated human brain capillaries. J Biol Chem 1986, 261:6536-6541.
26. Mizock BA, Sabelli HC, Dubin A, Javaid JI, Poulos A, Rackow EC. Septic encephalopathy: evidence for altered phenylalanine metabolism and comparison with hepatic encephalopathy. Arch Intern Med 1990, 150:443-449. 10.1001/archinte.150.2.443, 2302019.
27. Freund HR, Ryan JA, Fischer JE. Amino acid derangements in patients with sepsis: treatment with branched chain amino acid rich infusions. Ann Surg 1978, 188:423-430. 10.1097/00000658-197809000-00017, 1396972, 99098.
28. O'Kane RL, Hawkins RA. Na+-dependent transport of large neutral amino acids occurs at the abluminal membrane of the blood-brain barrier. Am J Physiol Endocrinol Metab 2003, 285:E1167-E1173.
29. Hawkins RA, O'Kane RL, Simpson IA, Vina JR. Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr 2006, 136:218S-226S.
30. Yudkoff M, Daikhin Y, Nissim I, Horyn O, Luhovyy B, Lazarow A, Nissim I. Brain amino acid requirements and toxicity: the example of leucine. J Nutr 2005, 135:1531S-1538S.
31. Basler T, Meier-Hellmann A, Bredle D, Reinhart K. Amino acid imbalance early in septic encephalopathy. Intensive Care Med 2002, 28:293-298. 10.1007/s00134-002-1217-6, 11904658.
32. von Meyenfeldt MF, Soeters PB, Vente JP, van Berlo CL, Rouflart MM, de Jong KP, Linden CJ, Gouma DJ. Effect of branched chain amino acid enrichment of total parenteral nutrition on nitrogen sparing and clinical outcome of sepsis and trauma: a prospective randomized double blind trial. Br J Surg 1990, 77:924-929. 10.1002/bjs.1800770828, 2118408.
33. García-de-Lorenzo A, Ortíz-Leyba C, Planas M, Montejo JC, Núñez R, Ordóñez FJ, Aragón C, Jiménez FJ. Parenteral administration of different amounts of branch-chain amino acids in septic patients: clinical and metabolic aspects. Crit Care Med 1997, 25:418-424. 10.1097/00003246-199703000-00008, 9118656.
34. Freund HR, Muggia-Sullam M, Peiser J, Melamed E. Brain neurotransmitter profile is deranged during sepsis and septic encephalopathy in the rat. J Surg Res 1985, 38:267-271. 10.1016/0022-4804(85)90037-X, 2858604.
35. Andreasen AS, Pedersen-Skovsgaard T, Mortensen OH, van Hall G, Moseley PL, Pedersen BK. The effect of glutamine infusion on the inflammatory response and HSP70 during human experimental endotoxaemia. Crit Care 2009, 13:R7. 10.1186/cc7696, 2688119, 19173710.
36. Oliveira GP, Oliveira MB, Santos RS, Lima LD, Dias CM, Ab' Saber AM, Teodoro WR, Capelozzi VL, Gomes RN, Bozza PT, Pelosi P, Rocco PR. Intravenous glutamine decreases lung and distal organ injury in an experimental model of abdominal sepsis. Crit Care 2009, 13:R74. 10.1186/cc7888, 2717436, 19454012.
37. Mizock BA, Dubin A, Rackow EC, Burke GS. Elevated cerebrospinal fluid glutamine in septic encephalopathy. J Clin Gastroenterol 1989, 11:362-363. 10.1097/00004836-198906000-00026, 2754226.
38. Ott P, Larsen FS. Blood-brain barrier permeability to ammonia in liver failure: a critical reappraisal. Neurochem Int 2004, 44:185-198. 10.1016/S0197-0186(03)00153-0, 14602081.
39. Lockwood AH. Controversies in ammonia metabolism: implications for hepatic encephalopathy. Metab Brain Dis 2007, 22:285-289. 10.1007/s11011-007-9059-0, 17828448.
40. Wright G, Davies NA, Shawcross DL, Hodges SJ, Zwingmann C, Brooks HF, Mani AR, Harry D, Stadlbauer V, Zou Z, Williams R, Davies C, Moore KP, Jalan R. Endotoxemia produces coma and brain swelling in bile duct ligated rats. Hepatology 2007, 45:1517-1526. 10.1002/hep.21599, 17523148.
41. Jeppsson B, Freund HR, Gimmon Z, James JH, von Meyenfeldt MF, Fischer JE. Blood-brain barrier derangement in sepsis: cause of septic encephalopathy?. Am J Surg 1981, 141:136-142. 10.1016/0002-9610(81)90026-X, 7457718.
42. Kadoi Y, Saito S. An alteration in the gamma-aminobutyric acid receptor system in experimentally induced septic shock in rats. Crit Care Med 1996, 24:298-305. 10.1097/00003246-199602000-00020, 8605805.
43. Pedersen HR, Ring-Larsen H, Olsen NV, Larsen FS. Hyperammonemia acts synergistically with lipopolysaccharide in inducing changes in cerebral hemodynamics in rats anaesthetised with pentobarbital. J Hepatol 2007, 47:245-252. 10.1016/j.jhep.2007.03.026, 17532089.
44. Andreasen AS, Krabbe KS, Krogh-Madsen R, Taudorf S, Pedersen BK, Møller K. Human endotoxemia as a model of systemic inflammation. Curr Med Chem 2008, 15:1697-1705. 10.2174/092986708784872393, 18673219.